Development of a Novel Anti-HER2 Monoclonal Antibody H < sub > 2 < /sub > Mab-181 for Gastric Cancer
In this study, we have developed a novel anti-HER2 mAb, H2Mab-181 (IgG1, kappa), through the immunization of mice with a purified recombinant extracellular domain of HER2. H2Mab-181 can specifically and sensitively detect HER2 in both flow cytometry and Western blot applications in gastric cancer cell lines and can also be utilized in immunohistochemical analyses of gastric cancer tissues. Together, H2Mab-181 could be useful for the diagnosis and therapy in gastric cancers.PMID:34424764 | DOI:10.1089/mab.2021.0021
Source: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy - Category: Microbiology Authors: Junko Takei Teizo Asano Tomohiro Tanaka Masato Sano Hideki Hosono Ren Nanamiya Nami Tateyama Masaki Saito Hiroyoshi Suzuki Hiroyuki Harada Mika K Kaneko Yukinari Kato Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Herceptin | Immunotherapy | Microbiology | Study